MedPath

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2

Not Applicable
Completed
Conditions
Refractive Error
Myopia
Interventions
Device: Verofilcon A contact lenses
Device: Somofilcon A contact lenses
Registration Number
NCT03888482
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study was to evaluate visual acuity at distance when wearing DDT2 contact lenses compared to Clariti contact lenses.

Detailed Description

Subjects were expected to attend 3 study visits and wear the DDT2 and Clariti study lenses in a crossover design for approximately 14 - 20 days (7 - 10 days for each product).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
154
Inclusion Criteria
  • Able to understand and sign an Informed Consent Form that has been approved by an Institutional Review Board.
  • Willing and able to attend all scheduled study visits as required per protocol.
  • Current wearer of spherical soft contact lenses.

Key

Exclusion Criteria
  • Any ocular condition that contraindicates contact lens wear.
  • Previous or current habitual wearer of clariti® or DAILIES TOTAL1® contact lenses.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Clariti, then DDT2Verofilcon A contact lensesSomofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
DDT2, then ClaritiVerofilcon A contact lensesVerofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
DDT2, then ClaritiSomofilcon A contact lensesVerofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
Clariti, then DDT2Somofilcon A contact lensesSomofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
Primary Outcome Measures
NameTimeMethod
Least Squares Mean Distance Visual Acuity With Study LensesDay 8, each product

Visual acuity was assessed and collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigative Site

🇺🇸

Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath